Standard BioTools Inc. (NASDAQ:LAB) Q2 2023 Results Conference Call August 8, 2023 5:00 PM ET
Company Participants
Scott Greenstone - Vice President, Investor Relations and Business Development
Michael Egholm - Chief Executive Officer and President
Jeff Black - Chief Financial Officer
Operator
Hello, and welcome to the Standard BioTools Inc., Second Quarter 2023 Financial Results Conference Call. As a reminder, this conference is being recorded.
It is now my pleasure to introduce your host, Scott Greenstone, Vice President, Investor Relations and Business Development. Thank you. Mr. Greenstone, you may now begin.
Scott Greenstone
Thank you, operator, and good afternoon, everyone. Welcome to the Standard BioTools Second Quarter 2023 Earnings Conference Call. At the close of market today, Standard BioTools released its financial results for the quarter ended June 30, 2023.
During this call, we will review our results and provide commentary on our financial and operating performance, market trends and strategic initiatives. Presenting for Standard BioTools today will be Michael Egholm, Chief Executive Officer and President; and Jeff Black, Chief Financial Officer.
During the call, we may make forward-looking statements about events and circumstances that have not yet occurred, including plans and projections for our business, our outlook for 2023 and future financial results and market trends and opportunities.
These statements are subject to substantial risks and uncertainties that may cause actual events or results to differ materially from current expectations. The forward-looking statements in this call are based on information currently available to us, and we disclaim any obligation to update these statements, except as may be required by law.
During the call, we will also present some financial information on a non-GAAP basis. We believe that these non-GAAP financial measures are useful in evaluating our core performance and as a baseline for assessing our future earnings potential of the Company.
We use these non-GAAP measures in our own evaluation of continuing operating performance. We encourage you to carefully consider our results under GAAP as well as our supplemental non-GAAP information and the reconciliation between these presentations, which are disclosed in the table accompanying our earnings release.
Please note that management will be referring to a slide presentation, including updated supplemental financial information within the webcast today, and this presentation is also posted on our website. I would also like to note that the Company will not be hosting a Q&A session following prepared remarks during today's conference call.